These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 24337040)
1. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells. Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040 [TBL] [Abstract][Full Text] [Related]
2. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis. Luo HB; Li B; Yuan WG; Xu CR J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630 [TBL] [Abstract][Full Text] [Related]
3. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma. Chiba T; Miyagi S; Saraya A; Aoki R; Seki A; Morita Y; Yonemitsu Y; Yokosuka O; Taniguchi H; Nakauchi H; Iwama A Cancer Res; 2008 Oct; 68(19):7742-9. PubMed ID: 18829528 [TBL] [Abstract][Full Text] [Related]
4. shRNA targeting Bmi1 impedes the self-renewal of cisplatin-enriched stem-like cells in human A549 cells. Xu Y; Hu YD; Zhou J; Zhang MH; Yuan WW; Luo Y Oncol Rep; 2012 Aug; 28(2):629-39. PubMed ID: 22664532 [TBL] [Abstract][Full Text] [Related]
5. [Effect of gene silencing of Bmi-1 on proliferation regulation of CD44+ nasopharyngeal carcinoma cancer stem-like cells]. Xu X; Liu Y; Li D; Su J; Hu J; Lu M; Yi F; Reng J; Chen W Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 May; 29(10):941-7. PubMed ID: 26596015 [TBL] [Abstract][Full Text] [Related]
6. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma. Teshima K; Nara M; Watanabe A; Ito M; Ikeda S; Hatano Y; Oshima K; Seto M; Sawada K; Tagawa H Oncogene; 2014 Apr; 33(17):2191-203. PubMed ID: 23686310 [TBL] [Abstract][Full Text] [Related]
7. Knockdown BMI1 expression inhibits proliferation and invasion in human bladder cancer T24 cells. Liang W; Zhu D; Cui X; Su J; Liu H; Han J; Zhao F; Xie W Mol Cell Biochem; 2013 Oct; 382(1-2):283-91. PubMed ID: 23820733 [TBL] [Abstract][Full Text] [Related]
8. [Analysis of the characteristics of side population cells in the human ovarian cancer cell line OVCAR-3]. Luo LJ; Zhao Z; Zeng JF; Liang B; Yang JX; Cao DY; Shen K Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):281-5. PubMed ID: 22781115 [TBL] [Abstract][Full Text] [Related]
9. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice. Chiba T; Seki A; Aoki R; Ichikawa H; Negishi M; Miyagi S; Oguro H; Saraya A; Kamiya A; Nakauchi H; Yokosuka O; Iwama A Hepatology; 2010 Sep; 52(3):1111-23. PubMed ID: 20648475 [TBL] [Abstract][Full Text] [Related]
10. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway. Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590 [TBL] [Abstract][Full Text] [Related]
11. Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin. Yang Y; Fan Y; Qi Y; Liu D; Wu K; Wen F; Zhao S Oncol Rep; 2015 Aug; 34(2):929-35. PubMed ID: 26081992 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene. Luo H; Yang R; Li C; Tong Y; Fan L; Liu X; Xu C Tumour Biol; 2017 Jul; 39(7):1010428317718414. PubMed ID: 28720065 [TBL] [Abstract][Full Text] [Related]
13. Bmi1 drives stem-like properties and is associated with migration, invasion, and poor prognosis in tongue squamous cell carcinoma. He Q; Liu Z; Zhao T; Zhao L; Zhou X; Wang A Int J Biol Sci; 2015; 11(1):1-10. PubMed ID: 25552924 [TBL] [Abstract][Full Text] [Related]
14. Concomitant targeting of multiple key transcription factors effectively disrupts cancer stem cells enriched in side population of human pancreatic cancer cells. Wang X; Liu Q; Hou B; Zhang W; Yan M; Jia H; Li H; Yan D; Zheng F; Ding W; Yi C; Hai Wang PLoS One; 2013; 8(9):e73942. PubMed ID: 24040121 [TBL] [Abstract][Full Text] [Related]
15. PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P. Huang B; Fu SJ; Fan WZ; Wang ZH; Chen ZB; Guo SJ; Chen JX; Qiu SP Cancer Lett; 2016 Jun; 376(1):148-54. PubMed ID: 27037060 [TBL] [Abstract][Full Text] [Related]
16. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1. Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430 [TBL] [Abstract][Full Text] [Related]
17. MAGE-A3 is highly expressed in a cancer stem cell-like side population of bladder cancer cells. Yin B; Zeng Y; Liu G; Wang X; Wang P; Song Y Int J Clin Exp Pathol; 2014; 7(6):2934-41. PubMed ID: 25031712 [TBL] [Abstract][Full Text] [Related]
18. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme. Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408 [TBL] [Abstract][Full Text] [Related]
19. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway. Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383 [TBL] [Abstract][Full Text] [Related]
20. Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog. Paranjape AN; Balaji SA; Mandal T; Krushik EV; Nagaraj P; Mukherjee G; Rangarajan A BMC Cancer; 2014 Oct; 14():785. PubMed ID: 25348805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]